Stay updated on Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Sign up to get notified when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.

Latest updates to the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe study record for the camostat and Artemisia annua COVID-19 outpatient trial is displayed with its study design, participant criteria, interventions, and primary outcome. The page also includes the trial’s terminated status and record dates.SummaryDifference61%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide NIH banner announces a website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe revision number in the footer of the 403 Forbidden page changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site revision displayed on the 403 error page changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an access-denied message and preventing viewing the study record.SummaryDifference20%

Stay in the know with updates to Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.